MARKET

NRXP

NRXP

Nrx Pharmaceuticals Inc
NASDAQ
1.990
+0.080
+4.19%
After Hours: 1.960 -0.03 -1.51% 19:26 02/09 EST
OPEN
1.940
PREV CLOSE
1.910
HIGH
1.995
LOW
1.820
VOLUME
469.93K
TURNOVER
--
52 WEEK HIGH
3.840
52 WEEK LOW
1.580
MARKET CAP
58.91M
P/E (TTM)
-0.8570
1D
5D
1M
3M
1Y
5Y
1D
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/9/26
TipRanks · 17h ago
Weekly Report: what happened at NRXP last week (0202-0206)?
Weekly Report · 22h ago
Psychedelic: Analyst initiates Definium, Helus with Buy ratings
TipRanks · 4d ago
Vanguard Total Stock Market ETF (VTI) Daily Update—2/5/26
TipRanks · 4d ago
NRX Pharmaceuticals Appoints Joseph M. Casper as Chief Operating Officer
Reuters · 02/02 22:16
NRX Pharmaceuticals ernennt Joseph M. Casper zum Chief Operating Officer
Reuters · 02/02 22:16
Vanguard Total Stock Market ETF (VTI) Daily Update—2/2/26
TipRanks · 02/02 12:39
Weekly Report: what happened at NRXP last week (0126-0130)?
Weekly Report · 02/02 09:59
More
About NRXP
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal depression, chronic pain, and PTSD. It is developing NRX-100 (preservative-free intravenous ketamine) and NRX-101, (oral D-cycloserine/lurasidone). NRX-100 has been awarded Fast Track Designation for the treatment of Suicidal Ideation in Depression, including Bipolar Depression. NRX-101 has been awarded Breakthrough Therapy Designation for the treatment of suicidal bipolar depression. NRx has filed an Abbreviated New Drug Application (ANDA) and initiated a New Drug Application filing for NRX-100 (IV ketamine) with an application for the Commissioner’s National Priority Voucher Program for the treatment of suicidal depression. Its subsidiary, HOPE Therapeutics, Inc., is a healthcare delivery company that is building a network of interventional psychiatry clinics.

Webull offers NRX Pharmaceuticals Inc stock information, including NASDAQ: NRXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRXP stock methods without spending real money on the virtual paper trading platform.